Telecommunications stock T-Mobile US Inc (NASDAQ:TMUS) was last seen down 1.5% to trade at $207.38, following a downgrade from Oppenheimer to "perform" from "outperform." The firm cited slowing industry subscriber growth, believing the company will have a hard time beating subscriber and free cash flow estimates.TMUS has had a volatile year on the charts, recently hitting a Nov. 6 one-year low of $199.41 after trading as high as $276.49 in March. The stock's rebound from those lows was met with resistance a ...

Veteran equity markets leader joins to oversee trading operations and advance cross-platform growth initiatives Accessibility StatementSkip Navigation NEW YORK, Nov. 17, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. – a leading investment bank, wealth manager, and subsidiary of Oppenheimer Holdings (NYSE: OPY) — today announced that Keith Peterson has joined the firm as Managing Director and Head of Cash Equity Sales and Trading. He will report to John Hellier, Senior Managing Director and Head of Equities. ...

Oppenheimer Asset Management Inc. acquired a new stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 5,568 shares of the biotechnology company’s stock, valued at approximately $245,000. Get Exelixis alerts: Other institutional investors and hedge funds have also made changes to their positions in the company. Belpointe Asset Management LLC purchased a new stake in shares of Exelixis d ...

Group 1 - The article does not provide any specific content related to a company or industry [1]

Core Laboratories Overview - Oppenheimer Asset Management Inc. reduced its holdings in Core Laboratories by 9.0%, owning 62,951 shares valued at $725,000 after selling 6,233 shares [2] - Institutional investors and hedge funds own 97.81% of Core Laboratories stock [3] Recent Hedge Fund Activity - Ariel Investments LLC increased its stake by 7.4%, now owning 10,342,025 shares valued at $155,027,000 after acquiring 709,455 shares [3] - Fred Alger Management LLC grew its position by 32.4%, owning 736,853 shares valued at $11,045,000 after purchasing 180,344 shares [3] - Rice Hall James & Associates LLC increased its stake by 71.2%, now owning 193,798 shares valued at $2,905,000 after acquiring 80,595 shares [3] Analyst Ratings and Forecasts - Stifel Nicolaus lowered the price target from $13.00 to $12.00, maintaining a "hold" rating [4] - Weiss Ratings upgraded from "sell (d+)" to "hold (c-)" [4] - Zacks Research upgraded from "strong sell" to "hold" [4] - The consensus rating for Core Laboratories is "Hold" with an average price target of $12.50 [4] Stock Performance and Financial Metrics - Core Laboratories stock opened at $15.95, with a market capitalization of $742.40 million [5] - The company has a debt-to-equity ratio of 0.41, quick ratio of 1.76, and current ratio of 2.37 [5] - The stock has a 52-week low of $9.72 and a high of $21.83 [5] Quarterly Earnings Results - Core Laboratories reported $0.22 EPS, exceeding estimates of $0.19 by $0.03, with revenue of $134.52 million [6] - Revenue increased by 0.1% year-over-year, with a net margin of 6.21% [6] - Guidance for Q4 2025 is set at 0.180-0.22 EPS [6] Dividend Announcement - Core Laboratories declared a quarterly dividend of $0.01 per share, with an annualized dividend of $0.04 and a yield of 0.3% [7] - The dividend payout ratio is currently 5.97% [7] Company Profile - Core Laboratories provides reservoir description and production enhancement services to the oil and gas industry [8] - The company operates through Reservoir Description and Production Enhancement segments [8]

Core Insights - CF Industries has seen significant changes in institutional investor positions, with notable increases in holdings by several hedge funds during the second quarter [1] - Analyst ratings for CF Industries have been mixed, with some brokerages lowering their price targets while others maintain a "hold" rating [2] - The company's stock has shown a slight increase, with a current market capitalization of $13.50 billion and a PE ratio of 10.88 [3] - CF Industries reported strong quarterly earnings, exceeding revenue expectations and showing a year-over-year revenue increase of 20.2% [4] - A quarterly dividend of $0.50 per share has been announced, reflecting a 2.4% dividend yield [5] Institutional Investor Activity - Brighton Jones LLC acquired a new stake worth approximately $469,000 in CF Industries during the second quarter [1] - Focus Partners Advisor Solutions LLC increased its holdings by 57.9%, now owning shares worth $558,000 after purchasing an additional 2,226 shares [1] - AlphaQuest LLC significantly boosted its holdings by 548.6%, now owning shares valued at $1,312,000 after acquiring 12,064 additional shares [1] - 93.06% of CF Industries' stock is owned by institutional investors [1] Analyst Ratings - Goldman Sachs reduced its price target from $96.00 to $94.00, maintaining a "neutral" rating [2] - BNP Paribas downgraded the stock from "strong-buy" to "hold" [2] - HSBC lowered its target price from $104.00 to $95.00, also rating it as "hold" [2] - The consensus rating for CF Industries is "Hold" with a target price of $97.54 [2] Financial Performance - CF Industries reported earnings of $2.37 per share, beating the consensus estimate of $2.35 by $0.02 [4] - The company achieved revenue of $1.89 billion, surpassing analyst estimates of $1.73 billion [4] - The net margin for the quarter was 20.19%, with a return on equity of 17.10% [4] - Analysts forecast earnings per share of 5.83 for the current year [4] Dividend Announcement - A quarterly dividend of $0.50 per share will be paid on November 28th, with a record date of November 14th [5] - This dividend represents an annualized amount of $2.00 and a yield of 2.4% [5] - The current dividend payout ratio stands at 26.11% [5] Company Overview - CF Industries engages in the manufacture and sale of hydrogen and nitrogen products for various industrial applications [7]

Investment Activity - Oppenheimer Asset Management Inc. purchased 21,513 shares of Artivion, Inc. valued at approximately $669,000, representing about 0.05% ownership at the end of the last quarter [2] - MCF Advisors LLC increased its holdings by 109.3%, now owning 1,176 shares worth $29,000 after buying an additional 614 shares [2] - Other institutional investors, including EntryPoint Capital LLC, Natixis Advisors LLC, and Zurcher Kantonalbank Zurich Cantonalbank, also increased their stakes in Artivion during the first quarter [2] Analyst Ratings - Citigroup maintained an "outperform" rating for Artivion [3] - Needham & Company raised the price target from $45.00 to $50.00 and assigned a "buy" rating [3] - The average rating for Artivion is "Moderate Buy" with a consensus target price of $43.97 [3] Stock Performance - Artivion's stock opened at $45.41, with a 52-week low of $21.97 and a high of $46.19 [4] - The company has a market capitalization of $2.14 billion and a PE ratio of -108.12 [4] Financial Results - Artivion reported $0.24 EPS for the last quarter, exceeding estimates of $0.11 by $0.13 [5] - Revenue for the quarter was $112.97 million, up 15.3% year-over-year, surpassing estimates of $107.96 million [5] - The company has set its FY 2025 guidance at EPS, with analysts forecasting $0.37 for the current fiscal year [5] Insider Transactions - SVP Jean F. Holloway sold 23,356 shares at an average price of $43.01, totaling approximately $1,004,541.56, reducing ownership by 11.95% [6] - SVP Marshall S. Stanton sold 18,200 shares at an average price of $44.02, totaling approximately $801,164.00, representing a 22.09% decrease in position [6] - Insiders have sold a total of 74,858 shares worth $3,250,129 over the last three months, with insiders owning 7.60% of the stock [6] Company Overview - Artivion, Inc. manufactures and distributes medical devices and implantable human tissues, including BioGlue and aortic arch stent grafts [8]

Core Insights - Oppenheimer Asset Management Inc. increased its stake in NEOS S&P 500 High Income ETF by 9.4% in Q2, owning 12,675 shares valued at $638,000 after purchasing an additional 1,086 shares [2] - Other institutional investors also increased their holdings, with LPL Financial LLC boosting its position by 55.2% and owning 1,290,478 shares valued at $61.8 million after acquiring 458,785 shares [3] - NEOS S&P 500 High Income ETF has a market capitalization of $4.36 billion, a P/E ratio of 25.58, and a beta of 0.71, with a 52-week price range of $41.60 to $52.78 [4] Institutional Activity - Cascade Wealth Advisors Inc. raised its stake by 78.4%, now owning 266,248 shares worth $12.3 million after buying 116,972 shares [3] - American Alpha Advisors LLC and Teamwork Financial Advisors LLC both established new stakes in the ETF, valued at approximately $4.24 million and $4.44 million respectively [3] - 3EDGE Asset Management LP also acquired a new stake worth about $3.91 million [3] Company Profile - NEOS S&P 500 High Income ETF primarily invests in total market equity, aiming for tax-efficient and high monthly income through active investments in S&P 500 stocks and options [5] - The fund employs a call spread strategy using SPX index option futures contracts [5]

Core Insights - Oppenheimer Asset Management Inc. increased its stake in Range Resources Corporation by 36.1% in Q2, owning 15,955 shares valued at $649,000 after acquiring an additional 4,230 shares [2] - Other institutional investors also increased their holdings, with GAMMA Investing LLC up by 4.7%, Public Employees Retirement System of Ohio by 0.4%, and Bessemer Group Inc. by 48.0% [3] - Range Resources reported a quarterly EPS of $0.57, exceeding analysts' expectations, with revenue of $748.53 million, a 21.7% increase year-over-year [6] Institutional Investment - Oppenheimer Asset Management Inc. now holds 15,955 shares after a 36.1% increase [2] - GAMMA Investing LLC increased its holdings by 4.7%, owning 6,013 shares valued at $245,000 [3] - Public Employees Retirement System of Ohio owns 73,294 shares valued at $2,981,000 after a 0.4% increase [3] - Bessemer Group Inc. boosted its stake by 48.0%, now holding 971 shares valued at $39,000 [3] - Institutional investors collectively own 98.93% of Range Resources' stock [3] Analyst Ratings and Price Targets - Weiss Ratings downgraded Range Resources from "buy (b-)" to "hold (c+)" [4] - Morgan Stanley reduced its price target from $44.00 to $42.00, maintaining an "equal weight" rating [4] - Royal Bank Of Canada raised its target price from $45.00 to $46.00 with a "sector perform" rating [4] - The consensus rating for the stock is "Hold" with a target price of $41.95 [4] Stock Performance - Range Resources stock opened at $35.58, with a one-year low of $29.48 and a high of $43.50 [5] - The company has a market capitalization of $8.47 billion, a PE ratio of 14.95, and a beta of 0.51 [5] Financial Performance - The company reported a net margin of 19.64% and a return on equity of 15.99% [6] - Revenue for the quarter was $748.53 million, surpassing expectations of $721.22 million [6] - The anticipated EPS for the current year is 2.02 [6] Dividend Information - Range Resources announced a quarterly dividend of $0.09 per share, representing an annualized dividend of $0.36 and a yield of 1.0% [7] - The dividend payout ratio is currently 15.13% [7]

Core Insights - JFrog has seen significant increases in institutional ownership, with 85.02% of its stock currently held by institutional investors and hedge funds [1] - Analysts have generally positive outlooks on JFrog, with multiple firms raising their target prices and maintaining "buy" or "outperform" ratings [2] - The company's recent quarterly earnings report showed a revenue increase of 23.5% year-over-year, surpassing consensus estimates [4] Institutional Holdings - Vanguard Group Inc. increased its position by 0.4%, owning 8,871,984 shares valued at $283.9 million after purchasing an additional 35,458 shares [1] - TimesSquare Capital Management LLC raised its holdings by 6.5%, now owning 3,622,911 shares valued at $115.9 million after an additional purchase of 222,635 shares [1] - AllianceBernstein L.P. significantly increased its position by 1,974.0%, owning 2,151,008 shares worth $68.8 million after acquiring 2,047,294 shares [1] Analyst Ratings - Canaccord Genuity Group raised its target price from $52.00 to $55.00, maintaining a "buy" rating [2] - KeyCorp increased its target price from $52.00 to $57.00, giving an "overweight" rating [2] - The average rating for JFrog's stock is "Moderate Buy" with a consensus target price of $53.44 [2] Stock Performance - JFrog's stock opened at $47.48, with a market cap of $5.54 billion and a PE ratio of -61.66 [3] - The stock has a 52-week range with a low of $27.00 and a high of $51.94 [3] Earnings Report - JFrog reported earnings per share (EPS) of $0.18, exceeding the consensus estimate of $0.16 by $0.02 [4] - Revenue for the quarter was $127.2 million, above the consensus estimate of $122.8 million [4] - The company has set FY 2025 guidance at 0.680-0.70 EPS and Q3 2025 guidance at 0.150-0.17 EPS [4] Insider Transactions - CRO Tali Notman sold 13,067 shares at an average price of $50.26, reducing her position by 1.94% [5] - Director Yvonne Wassenaar sold 1,372 shares at an average price of $47.94, decreasing her ownership by 4.47% [5] - Over the last ninety days, insiders sold 481,492 shares worth $23.1 million, with insiders currently owning 14.10% of the stock [5] Company Overview - JFrog Ltd. provides a hybrid software supply chain platform, including products like JFrog Artifactory and JFrog Xray, which help organizations manage and secure their software packages [7]